Latest news
Neurizon advances ALS trial in Q4 FY26 - The AustralianThe Australian · Tue, 04 Aug 2026 03:12:00 GMTNeurizon secures up to $17.5 million in non-dilutive R&D financing - BiotechDispatchBiotechDispatch · Mon, 03 Aug 2026 23:09:40 GMTNUZ:ASX Announcement - Neurizon Enters Strategic R&D Financing Facility - 31 Jul 2026 - Market IndexMarket Index · Fri, 31 Jul 2026 09:58:07 GMTNeurizon Secures Up to $17.5 Million Non-Dilutive R&D Financing Facility with Dare Capital - KalkineKalkine · Fri, 31 Jul 2026 07:00:00 GMTNeurizon Secures $17.5m Non-Dilutive R&D Financing to Fund ALS Trial - TipRanksTipRanks · Fri, 31 Jul 2026 05:41:24 GMT